Venlafaxine treatment stimulates expression of brain-derived neurotrophic factor protein in frontal cortex and inhibits long-term potentiation in hippocampus.

Cooke, J D; Grover, L M; Spangler, P R

Cooke, J D; Grover, L M; Spangler, P R.

Affiliation

Cooke JD; Department of Pharmacology, Physiology and Toxicology, Marshall University Joan C. Edwards School of Medicine, Robert C. Byrd Biotechnology Science Center, One John Marshall Drive, Huntington, WV 25755, USA.

Neuroscience ; 162(4): 1411-9, 2009 Sep 15.

Article in En | MEDLINE | ID: mdl-19464349

Subject(s)

Adrenergic Uptake Inhibitors/pharmacology; Brain-Derived Neurotrophic Factor/biosynthesis; Cyclohexanols/pharmacology; Frontal Lobe/drug effects; Hippocampus/drug effects; Long-Term Potentiation/drug effects; Selective Serotonin Reuptake Inhibitors/pharmacology; Animals; Frontal Lobe/metabolism; Hippocampus/physiology; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Venlafaxine Hydrochloride

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Selective Serotonin Reuptake Inhibitors / Long-Term Potentiation / Adrenergic Uptake Inhibitors / Brain-Derived Neurotrophic Factor / Cyclohexanols / Frontal Lobe / Hippocampus Limits: Animals Language: En Journal: Neuroscience Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google